SNPMiner Trials (Home Page)
Report for SNP rs10033900
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 A Multicenter Study on the Investigation of Previously Verified Leading Gene Polymorphisms Related to Age-related Macular Degeneration in Turkish Population
The purpose of this study is to determine whether common genetic polymorphisms that have been verified to be related to age-related macular degeneration (AMD) in some populations are also associated with AMD in Turkish population
NCT02248324 Age-related Macular Degeneration MeSH:Macular Degeneration
In the introduced projects study, the relationship of eight different gen polymorphisms (CFH rs1061170 and rs1410996, LOC387715 / ARMS2 gene rs10490924, C2 gene rs9332739, CFB gene rs641153, CFI rs10033900 , HTRA-1 gene rs11200638, C3 rs2230199) will be studied in 2800 patients with high risk intermediate and late stage AMD and 2200 age-matched control subjects.
Primary Outcomes
Description: Gene polymorphisms of 8 region with identification of homozygous, heterozygote and wild type genotyping and alleles
Measure: rate of homozygous, heterozygous or wild type genotype and allels Time: at the end of third years